Day: August 19, 2020

Hexagon to transfer CNG LDV to its g-mobility business – establishing Hexagon Purus as a pure e-mobility business

Written by Customer Service on August 19, 2020. Posted in Public Companies.

Hexagon Composites announces today the transfer of its Compressed Natural Gas Light Duty Vehicle (CNG LDV) activities from Hexagon Purus, to Hexagon’s gas-mobility (g-mobility) business. This transfer will establish Hexagon Purus as a pure e-mobility business.Post initial COVID-19 disruption, de-carbonization is high up on the global agenda and there is a strong push to limit carbon emissions. This momentum is evidenced by many government responses which have put attention firmly back on climate change, renewable energy and new green technologies. This is creating unprecedented opportunities for both g-mobility and e-mobility players.Hexagon Group’s business covers the spectrum of low carbon and no carbon mobility solutions. Its strategy focuses along three axes; g-mobility, e-mobility, and world class manufacturing.Since January 2020,...

Thin Film Electronics ASA – Nomination Committee’s proposal to the Extraordinary General Meeting

Written by Customer Service on August 19, 2020. Posted in Public Companies.

Oslo, 19 August 2020Thinfilm is Energizing Innovation™ with ultrathin, flexible, and safe energy storage solutions for wearable devices, connected sensors, and beyond. Thinfilm’s innovative solid-state lithium battery (SSLB) technology is uniquely positioned to enable the production of powerful, lightweight, and cost-effective rechargeable batteries for diverse applications. The company’s state-of-the-art flexible electronics manufacturing facility, located in the heart of Silicon Valley, combines patented process technology and materials innovation with the scale of roll-to-roll production methods to bring the advantages of SSLB technology to established and expanding markets. Thin Film Electronics ASA is a publicly listed company in Norway with corporate headquarters in Oslo and global headquarters in San Jose, California.Contact:Kevin...

Continued stable growth – the effects of Covid-19 have been fended off relatively well

Written by Customer Service on August 19, 2020. Posted in Earnings Releases And Operating Results.

Sales rose by 6.0% to SEK 12,572 million (SEK 11,856 million) Profit after net financial items rose by 8.3% to SEK 1,222 million (SEK 1,128 million)Earnings per share amounted to SEK 1.79 (SEK 1.71)Acquisition of Serbian TIKI Group, Turkish Üntes, Dutch Nathan, German WATERKOTTE, Swedish VEÅ and Italian Termtech (after end of period)A final decision on dividend for 2019 will be taken after the end of Q3“Demand has varied between different market segments where those with clear sustainability characteristics, such as heat pumps, continued to perform well. It is also gratifying that demand in the semiconductor industry has shown good growth, whereas the domestic appliance sector, traditional automotive industry and oil and gas industry have seen weaker growth. After a weak period, demand for stoves, which are considered durable goods, increased...

Fortsatt stabil utveckling – effekterna av Covid-19 har kunnat pareras relativt väl

Written by Customer Service on August 19, 2020. Posted in Earnings Releases And Operating Results.

Omsättningen ökade med 6,0% till 12.572 Mkr (11.856 Mkr) Resultatet efter finansnetto ökade med 8,3% till 1.222 Mkr (1.128 Mkr) Vinsten per aktie uppgick till 1,79 kr (1,71 kr) Förvärv av serbiska TIKI Group, turkiska Üntes, nederländska Nathan, tyska WATERKOTTE, svenska VEÅ samt italienska Termotech (efter periodens utgång)Slutligt ställningstagande till eventuell utdelning för 2019 efter utgången av kvartal tre ”Efterfrågebilden har varierat mellan olika marknadssegment där de med tydlig hållbarhetsprägel, exempelvis värmepumpar, haft en fortsatt god utveckling. Glädjande är också att efterfrågan inom halvledarindustrin uppvisat en god tillväxt. Såväl vitvarusektorn som den traditionella fordonsindustrin samt olje- och gasindustrin har däremot haft en svagare utveckling. För kaminer, som betraktas som sällansköpsprodukter, har efterfrågan...

Verona Pharma Initiates Multiple Dose Part of Phase 2 Clinical Trial with pMDI Formulation of Ensifentrine in COPD

Written by Customer Service on August 19, 2020. Posted in Public Companies.

LONDON and RALEIGH, N.C., Aug. 19, 2020 (GLOBE NEWSWIRE) — Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces the initiation of the second, multiple dose, part of a Phase 2 trial to evaluate the pressurized metered-dose inhaler (“pMDI”) formulation of ensifentrine in patients with moderate to severe chronic obstructive pulmonary disease (“COPD”). Results from the study (Part B) are expected in the first half of 2021.Positive efficacy and safety data from the first, single dose, part of the study (Part A) in 40 patients with moderate to severe COPD were announced by the Company on March 31, 2020. The results demonstrated a statistically significant and clinically meaningful increase in lung function as measured by forced expiratory volume...

CENTOGENE Opens Walk-In COVID-19 Testing Facility at Hamburg Airport

Written by Customer Service on August 19, 2020. Posted in Public Companies.

CENTOGENE expands its SARS-CoV-2 testing solution to Hamburg Airport after successfully launching the first walk-in COVID-19 test facility at Frankfurt Airport in June 2020 in cooperation with LufthansaCompany’s PCR tests now available for passengers departing from Hamburg, and returning to Hamburg from non-risk countries only, as well as the general publicExpansion of testing to Hamburg Airport further paves the way towards a new normal for our societies and economiesCAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Aug. 19, 2020 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, announced today the opening of its new walk-in COVID-19 test facility...

OKYO Pharma Limited (“OKYO” or the “Company”) – Appointment of Dr. Napoleone Ferrara to Serve on Its Scientific Advisory Board

Written by Customer Service on August 19, 2020. Posted in Public Companies.

LONDON, Aug. 19, 2020 (GLOBE NEWSWIRE) — OKYO, the life sciences and biotechnology company, focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain, is pleased to announce that that Dr. Napoleone Ferrara, MD, Professor at the University of California San Diego Medical Center, has agreed to serve on its scientific advisory board (SAB).Dr. Ferrara is a member of The National Academy of Sciences and has received numerous prestigious awards, including the Lasker Award and the Breakthrough Prize in Life Sciences. His research on understanding the role of angiogenesis and vascular endothelial growth factor (VEGF) in cancer development, led to the discovery that VEGF is a key mediator of angiogenesis associated with intraocular neovascular syndromes. This pioneering research...

Interim Report Q2 2020

Written by Customer Service on August 19, 2020. Posted in Earnings Releases And Operating Results.

The Interim Report for the 2nd Quarter 2020 for A.P. Møller – Mærsk A/S is hereby enclosed.CEO of A.P. Møller – Mærsk A/S, Søren Skou, states:“As expected, the second quarter was materially impacted by COVID-19 and our focus remained on protecting our employees from the virus, serving our customers by keeping our global network of ships sailing and our ports, warehouses and inland transportation networks operating, and helping the societies we are part of fight the virus.I am pleased that we despite the headwinds, continued our track record of improving earnings and free cash flow. Our operating earnings improved by 25%, marking the eight-consecutive quarter with year-on-year improvements, driven by strong cost performance across all our businesses, lower fuel prices and higher freight rates in Ocean and increased profitability...

Halvårsrapport 2020 (kun på engelsk)

Written by Customer Service on August 19, 2020. Posted in Earnings Releases And Operating Results.

Vedhæftet halvårsrapport 2020 for A.P. Møller – Mærsk A/S (kun på engelsk).Administrerende direktør i A.P. Møller – Mærsk A/S, Søren Skou, udtaler:”Andet kvartal var som ventet kraftigt påvirket af COVID-19. Vi fokuserede på at beskytte vores medarbejdere og hjælpe såvel kunder som de omgivende samfund ved at opretholde driften af det global netværk af skibe, havne, varehuse og landtransport.Jeg tilfreds med, at vi trods modvind i markedet fortsætter med at styrke vores indtjening og frie pengestrømme. For ottende kvartal i træk stiger vores driftsindtjening, hvilket især skyldes stram styring af omkostninger, lavere oliepris og højere fragtrater i Ocean-forretningen samt en øget rentabilitet i Logistics & Services.Med et solidt resultat og en stærk balance står vi til at komme styrket gennem krisen, både finansielt og...

CytoDyn Requests “Fast Track Approval” for COVID-19 Patients from U.K.’s Regulatory Agency MHRA based on its Top-line Report Showing Statistically Significant Endpoint, NEWS2 (p < 0.023) and Notable Safety Results

Written by Customer Service on August 19, 2020. Posted in Public Companies.

VANCOUVER, Washington, Aug. 18, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today the Company provided its Top-line Report from its recently completed Phase 2 clinical trial for patients with mild-to-moderate COVID-19 symptoms to Medicines and Healthcare Products Regulatory Agency (MHRA), an executive agency of the U.K. government sponsored by the Department of Health and Social Care. The Company requested the regulatory pathway for Fast Track approval noting the efficacy and safety results from the Phase 2 trial.Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn, stated, “As we recently reported, we are working...

Day: August 19, 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals